The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Genzyme Corp.  (GENZ) Trade Now »     Rate GENZ  -  Discuss GENZ  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks
This Quarter's Sentiment:
All:
89.5%
Top:
100.0%
Rate GENZ:


Discuss
        


Arrow_up
Arrow_down
Free report on upcoming FDA panel decision of Corvu..    1 point   Last updated 106 days ago
Posted by
amritadas   N/A
FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by the FDA will increase significantly. If the drug gets approved by the FDA, it is estimated to achieve Peak sales of $350 million. To read about our ex... ...  more »
0 Comment  |  Related to:  GENZ

Arrow_up
Arrow_down
3 Clean Energy Stocks For An Obama Presidency    1 point   Last updated 376 days ago
Posted by
128_by_128_cp
Contrarian Profits   71%
How will the stock markets respond to a new US president? Martin Delholm says the impact will be less than some people expect. But some sectors will benefit from a regime change. With Obama the clear favourite to win, Martin recommends three clean energy stocks likely to gain from new subsidies. I... ...  more »
0 Comment  |  Related to:  PFE GENZ DNA INDU COMP


ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.57% 370
2 18.14 +68.57% 207
3 17.66 +25.68% 53
4 13.47 +14.32% 61
5 12.13 +77.15% 34


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on GENZ

Visit streetinsider.com


More Resources

Graphic_arrow1 About Genzyme Corp. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch